Imodium (Loperamide Hydrochloride)

Imodium is an antidiarrheal that acts on intestinal motility and fluid absorption.

• Acute nonspecific diarrhea: decreases stool frequency and improves consistency.
• Chronic diarrhea associated with inflammatory bowel disease: helps control persistent loose stools.
• Travelers' diarrhea: provides symptomatic relief for sudden onset of watery stools during travel.

• Loperamide Hydrochloride acts as a peripheral μ‑opioid receptor agonist in the gastrointestinal tract. By binding to these receptors, it inhibits acetylcholine release, reduces peristaltic activity, and prolongs intestinal transit time, allowing greater water reabsorption and resulting in firmer stools without significant central nervous system effects.

Adverse reactions may occur with any antidiarrheal medication.

Common Side Effects

• Constipation: reduced bowel movements or hard stools.
• Abdominal cramps: mild to moderate discomfort.
• Nausea: feeling of sickness.
• Dizziness: transient light‑headedness.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Paralytic ileus: severe bowel obstruction requiring medical attention.
• Cardiac arrhythmias: especially with high doses or drug interactions.
• Severe allergic reactions: rash, itching, swelling, or breathing difficulty.
• Toxic megacolon: rare but life‑threatening colonic dilation.
• Central nervous system depression: extreme drowsiness or confusion.

Before using Imodium, consider the following safety points.

• Underlying infection: avoid if diarrhea is caused by bacterial toxins or invasive pathogens.
• Severe liver disease: use with caution as metabolism may be impaired.
• Pediatric use: not recommended for children under a specified age without medical advice.
• Pregnancy and breastfeeding: discuss risks with a healthcare professional.
• Concomitant opioid use: may increase risk of central effects.
• Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Loperamide can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels.
• P-glycoprotein inhibitors (e.g., quinidine, ritonavir): raise risk of cardiac toxicity.
• Other opioid agonists: can enhance central opioid effects.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: may worsen constipation.
• Antidiarrheal combinations (e.g., bismuth subsalicylate): overlapping mechanisms.
• Certain antifungals (e.g., itraconazole): may modestly increase exposure.